Idiopathic Intracranial Hypertension
📧 Sign up to get email alerts when something new happens for Idiopathic Intracranial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
This clinical trial update discusses a study evaluating the relationship between body mass index and treatment response in idiopathic intrac…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide [NA]
A clinical trial update showing ongoing recruitment to evaluate venous stenting as a treatment option for idiopathic intracranial hypertensi…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Evaluating Raised Intracranial Pressure Using MR Elastography [NA]
A Mayo Clinic clinical trial is evaluating the use of MR elastography to assess raised intracranial pressure in idiopathic intracranial hype…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure [Phase 4]
Phase 4 clinical trial evaluating semaglutide versus standard weight management for weight reduction and change in intracranial pressure in …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost Effectiveness [NA]
A University of Birmingham trial is recruiting to compare shunts versus stents for idiopathic intracranial hypertension, evaluating clinical…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
This Clinical Trial Update describes a post-market clinical follow-up study of the CODMAN CERTAS Programmable Valve for hydrocephalus and re…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE) [Phase 3]
A Phase 3 trial evaluating stent implantation versus medical therapy for idiopathic intracranial hypertension, focusing on patients with ven…
-
FDA approval · 2026-01-08FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for acetazolamide from Strides Pharma Science Limited. The document indicates approval of a suppleme…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension. [NA]
ClinicalTrials.gov entry for a study comparing stenting versus other neurosurgical treatment in idiopathic intracranial hypertension, curren…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Tirzepatide in Idiopathic Intracranial Hypertension Trial [Phase 4]
Duke University is conducting a Phase 4 trial of tirzepatide for idiopathic intracranial hypertension, with enrollment not yet started.
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: MR Lymphatic Imaging in Idiopathic Intracranial Hypertention [NA]
A completed clinical trial investigating MR lymphatic imaging for idiopathic intracranial hypertension, sponsored by INSERM (France).
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects. [NA]
This document is a clinical trial update describing a study on multifocal chromatic pupilloperimetry in patients with pseudotumor cerebri an…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase [NA]
An early-phase clinical trial evaluating intracranial venous stenting for idiopathic intracranial hypertension is currently recruiting at Un…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Prospective Ocular Imaging for Intracranial Pressure Evaluation
A prospective ocular-imaging trial sponsored by King's College Hospital NHS Trust is recruiting to evaluate intracranial pressure in idiopat…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Assessment of Venous Drainage in Idiopathic Intracranial Hypertension [NA]
The trial assessing venous drainage in idiopathic intracranial hypertension is currently active and not recruiting.
-
FDA approval · 2025-05-30FDA Approved: ACETAZOLAMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for a generic acetazolamide product.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
NASA's clinical trial is investigating astronaut vision issues in a ground-analog population affected by Polycystic Ovary Syndrome and Idiop…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Advanced Neuroimaging in Idiopathic Intracranial Hypertension
A clinical trial at Thomas Jefferson University is evaluating advanced neuroimaging techniques in idiopathic intracranial hypertension to st…
-
FDA approval · 2025-03-12FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for acetazolamide submitted by Ajanta Pharma USA Inc.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Dural Venous Sinus Stent in Idiopathic Intracranial Hypertension [NA]
This clinical trial update outlines a study evaluating the use of a dural venous sinus stent for idiopathic intracranial hypertension, spons…
-
FDA approval · 2025-01-27FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc. under an Abbreviated New Drug Application.
-
FDA approval · 2024-11-26FDA Approved: ACETAZOLAMIDE EXTENDED-RELEASE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application from Micro Labs Limited for an extended-release formulation of acetazolamide.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: VEHICLE Registry: Venous Stenting for IIH in the MENA Region
The VEHICLE Registry is evaluating venous stenting as a treatment for idiopathic intracranial hypertension (IIH) in the Middle East and Nort…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial [NA]
The clinical trial comparing operative procedures versus endovascular neurosurgery for untreated pseudotumor cerebri/idiopathic intracranial…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension
A recruiting clinical trial is evaluating ocular perfusion in patients with idiopathic intracranial hypertension.